Literature DB >> 3484389

Spontaneous production of a suppressor factor by the human macrophage-like cell line U937. I. Suppression of interleukin 1, interleukin 2, and mitogen-induced blastogenesis in mouse thymocytes.

H Fujiwara, J J Ellner.   

Abstract

The human macrophage-like cell line U937 spontaneously produced a nondialyzable factor that inhibited interleukin 1 (IL 1), interleukin 2 (IL 2), and phytohemagglutinin (PHA)-induced blastogenesis in mouse thymocytes. The suppression by U937 supernatant factor occurred independently of the concentration of IL 1 or PHA, indicating that it was noncompetitive. The U937 suppressor factor was not cytotoxic for thymocytes, nor did it affect the spontaneous proliferation of T lymphoblastoid cell lines and U937. Physicochemical characterization showed that the U937 suppressor factor was nondialyzable, partially inactivated by heat treatment (56 degrees C), ammonium sulfate (67% saturation) precipitable, sensitive to pH 2.5, and resistant to freeze-thawing. Molecular weight of the factor inhibiting co-mitogenic IL 1 activity was approximately 85,000, as estimated by gel filtration. The U937 cell line may provide a model for the study of mechanisms and mediators of immunosuppression by mononuclear phagocytes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3484389

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo.

Authors:  R M Locksley; S Crowe; M D Sadick; F P Heinzel; K D Gardner; M S McGrath; J Mills
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

2.  Production of an interleukin-1 inhibitor by cell line P388D1 murine macrophages stimulated with Haemophilus actinomycetemcomitans lipopolysaccharide.

Authors:  T Nishihara; T Koga; S Hamada
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

3.  Isolation and purification of ILS, an interleukin 1 inhibitor produced by human gingival epithelial cells.

Authors:  L J Walsh; P E Lander; G J Seymour; R N Powell
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

4.  Suppression of murine macrophage interleukin-1 release by the polysaccharide portion of Haemophilus actinomycetemcomitans lipopolysaccharide.

Authors:  T Nishihara; T Koga; S Hamada
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

5.  Suppressor cell activity of human alveolar macrophages in interstitial lung diseases.

Authors:  E M Fireman; S Ben Efraim; J Greif; S Kivity; M R Topilsky
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

6.  A human urine-derived interleukin 1 inhibitor. Homology with deoxyribonuclease I.

Authors:  D L Rosenstreich; J H Tu; P R Kinkade; I Maurer-Fogy; J Kahn; R W Barton; P R Farina
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

7.  Improvement of macrophage dysfunction by administration of anti-transforming growth factor-beta antibody in EL4-bearing hosts.

Authors:  H Maeda; S Tsuru; A Shiraishi
Journal:  Jpn J Cancer Res       Date:  1994-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.